Melbye, Sigurd Arne http://orcid.org/0000-0003-1514-5424
Stanislaus, Sharleny
Vinberg, Maj
Frost, Mads
Bardram, Jakob Eyvind
Sletved, Kimie
Coello, Klara
Kjærstad, Hanne Lie
Christensen, Ellen Margrethe
Faurholt-Jepsen, Maria
Kessing, Lars Vedel
Clinical trials referenced in this document:
Documents that mention this clinical trial
Mood, activity, and sleep measured via daily smartphone-based self-monitoring in young patients with newly diagnosed bipolar disorder, their unaffected relatives and healthy control individuals
https://doi.org/10.1007/s00787-020-01611-7
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (722561)
Article History
Received: 14 April 2020
Accepted: 27 July 2020
First Online: 2 August 2020
Conflict of interest
: SM, SS, KC, HLK, KS, and MFJ have no conflicts to declare. LVK has, within the preceding 3 years, been a consultant for Lundbeck. MV has the last 3 years been a consultant for Sunovion, Janssen, and Lundbeck. EMC has been a consultant for Eli Lilly, Astra Zeneca, Servier, Bristol-Myers Squibb, Lundbeck, and Medilink within the last 3 years. JEB and MF are co-founders and shareholders of Monsenso ApS.
: The Bipolar Illness Onset (BIO) study has been approved by the ethics committee in the Capital Region, Copenhagen, Denmark (Ref. nr. H-7-2014-007) and the Danish Data Protection Agency, Capital Region of Copenhagen (Protocol no.: RHP-2015-023).